Evidence map›Paper›PMID 41287791›Full record

ArticleFrontiers in genetics2025

Construction of a HSC activation-related lncRNA-miRNA-mRNA ceRNA regulatory network reveals potential molecules involved in liver fibrosis.

Kaiqiang Wan, Qiong Zhou, Ruirui Feng, Tao Liu, Chang Fan, Xue Pang, Zhongliang Li, Qiumei Zhou

Abstract read
In one paragraph

Article in Frontiers in genetics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Kaiqiang WanExperimental Center of Clinical Research, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Qiong ZhouExperimental Center of Clinical Research, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Ruirui FengExperimental Center of Clinical Research, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Tao LiuExperimental Center of Clinical Research, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Chang FanExperimental Center of Clinical Research, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Xue PangExperimental Center of Clinical Research, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Zhongliang LiDepartment of Laboratory Medicine, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.
Qiumei ZhouExperimental Center of Clinical Research, The First Affiliated Hospital of Anhui University of Chinese Medicine, Hefei, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Liver fibrosis (LF) represents a progressive pathophysiological consequence of persistent liver injury. Although the competitive endogenous RNA (ceRNA) network serves as a critical regulator in diverse disease pathogenesis, its molecular underpinnings in LF and fibrogenic mediators remain unknown. Objective: In this study, we aimed to systematically probe the LF-related ceRNA regulatory axis and identify the potential molecules involved in the activation of hepatic stellate cells (HSCs). Methods and Results: Based on the whole transcriptome RNA sequencing, 401 lncRNAs, 60 miRNAs, and 1,224 mRNAs were identified between model and normal liver tissue samples. Then, through target gene prediction, an lncRNA-miRNA-mRNA (LMM) ceRNA network comprising four differentially expressed lncRNAs (DE lncRNAs), six DE miRNAs, and 148 DE mRNAs was established. The expression levels of these RNAs were verified by RT-qPCR. Functional annotation via the Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichment analysis revealed that target mRNAs of co-dysregulated lncRNAs and miRNAs in model groups were significantly enriched in multiple pathways, such as unsaturated fatty acids and TGF-β signaling pathways. Notably, four hub mRNAs (HMGCR, SREBF-1, TGF-β3, and FBN1) were identified by constructing a protein-protein interaction (PPI) network with the 148 DE mRNAs. Importantly, the dual-luciferase reporter assay confirmed the existence of specific binding sites among lncRNA H19, miR-148a-3p, and FBN1. Finally, the gene expression levels were verified by RT-qPCR in TGF-β1-induced JS-1 cells, revealing that five lncRNA-miRNA-mRNA relationship pairs containing H19, miR-130a-3p, miR-148a-3p, TGF-β3, FBN1, and HMGCR were involved in the activation of HSCs. Conclusion: In this study, an HSC activation-related ceRNA network was successfully established in mice liver tissue, which could provide a novel framework for elucidating pathogenic mechanisms and identifying clinically relevant prognostic markers in LF progression.

Indexed as

competitive endogenous RNAhepatic stellate cellsliver fibrosislong noncoding RNAwhole transcriptome sequencing

Identifiers

PMID41287791
PMCPMC12640689

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.